Barry S. Ticho
Equibles does not estimate personal net worth.
About Barry S. Ticho
Barry S. Ticho has spoken on 1 earnings call across 1 company, most recently for Stoke Therapeutics, Inc. on October 29, 2026. The companies whose calls Barry S. Ticho spoke on are classified in the Healthcare sector.
Barry S. Ticho on recent calls
“I'll start by expanding on our Phase III progress that Ian mentioned. EMFEROR is a global, double-blind, sham-controlled Phase III study of Zareba Nursin in patients with Dravet syndrome.”